Top banner. Image of Xolair resources displayed on a laptop, smartphone and in physical guides. Image of  pre-filled syringe. Text: XOLAIR® (omalizumab) Patient Resources for the treatment of CSU.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]